Refine Search

New Search

Results: 2

(searched for: doi:10.1038/s41591-021-01345-2)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
Peng Jiang, , , , Raymond R. Tan, Siming You,
Published: 30 June 2021
Energy, Volume 235, pp 121315-121315; https://doi.org/10.1016/j.energy.2021.121315

Abstract:
Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolonged immunisation campaign for COVID-19 is likely. The impacts are geographically dispersed across sectors and regions, creating real and virtual 4E footprints that occur at different timescales. Decision-makers in industry and governments have to act, unify, resolve, and work together to implement more sustainable COVID-19 vaccination management globally and locally to minimise the 4E footprints. Potential practices include using renewable energy in production, storage, transportation and waste treatment, using better product design for packaging, using the Internet of Things (IoT) and big data analytics for better logistics, using real-time database management for better tracking of deliveries and public vaccination programmes, and using coordination platforms for more equitable vaccine access. These practices raise global challenges but suggest solutions with a 4E perspective, which could mitigate the impacts of global vaccination campaigns and prepare sustainably for future pandemics and global warming.
, Elizabeth Littlewood, Samantha Gascoyne, Dean McMillan, David Ekers, Carolyn A Chew-Graham, Cathy Creswell, John Wright
Published: 1 June 2021
The Lancet Psychiatry, Volume 8, pp 647-650; https://doi.org/10.1016/s2215-0366(21)00204-2

Abstract:
COVID-19 prompted rapid mobilisation of health services and medical science in the face of unprecedented challenges. When COVID-19 emerged in 2020, medical science delivered, and delivered quickly. Using large-scale multicentre trials, researchers in partnership with health services established the ability of cheap and scalable interventions (such as corticosteroids) to save lives, and rapidly showed the futility of anecdotally endorsed repurposed drugs (such as hydroxychloroquine). The effectiveness of vaccinations was quickly established in phase 2 and 3 trials, providing the confidence to roll out successful vaccine programmes.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top